These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 532989)
1. Effects of serotonin antagonists in sexually impotent men. Ambrosi B; Travaglini P; Gaggini M; Moriondo P; Elli R; Bara R; Faglia G Andrologia; 1979; 11(6):475-7. PubMed ID: 532989 [TBL] [Abstract][Full Text] [Related]
2. Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion. Ferrari C; Caldara R; Romussi M; Rampini P; Telloli P; Zaatar S; Curtarelli G Neuroendocrinology; 1978; 25(6):319-28. PubMed ID: 662080 [TBL] [Abstract][Full Text] [Related]
3. Study of the effects of bromocriptine on sexual impotence. Ambrosi B; Bara R; Travaglini P; Weber G; Beck Peccoz P; Rondena M; Elli R; Faglia G Clin Endocrinol (Oxf); 1977 Nov; 7(5):417-21. PubMed ID: 338206 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects. Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379 [TBL] [Abstract][Full Text] [Related]
5. Male diabetic sexual impotence: effects of dopaminergic agents. Pierini AA; Nusimovich B Arch Androl; 1981 Jun; 6(4):347-50. PubMed ID: 6788008 [TBL] [Abstract][Full Text] [Related]
6. Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women. Pontiroli AE; Alberetto M; Pellicciotta G; De Castro e Silva E; De Pasqua A; Girardi AM; Pozza G Acta Endocrinol (Copenh); 1980 Mar; 93(3):271-6. PubMed ID: 7376792 [TBL] [Abstract][Full Text] [Related]
7. Antiserotonin treatment of hyperprolactinemic amenorrhea: long-term follow-up with metergoline, methysergide, and cyproheptadine. Crosignani PG; Peracchi M; Lombroso GC; Reschini E; Mattei A; Caccamo A; D'Alberton A Am J Obstet Gynecol; 1978 Oct; 132(3):307-12. PubMed ID: 707571 [TBL] [Abstract][Full Text] [Related]
8. A study of prolactin, follicle-stimulating hormone, and luteinizing hormone in puerperium: spontaneous variations and the effect of metergoline. Falsetti L; Voltolini AM; Pollini C; Pontiroli AE Fertil Steril; 1982 Mar; 37(3):397-401. PubMed ID: 6800850 [TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine. Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788 [No Abstract] [Full Text] [Related]
10. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride. Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483 [TBL] [Abstract][Full Text] [Related]
11. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility. Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450 [TBL] [Abstract][Full Text] [Related]
12. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration. Delitala G Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients. Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367 [TBL] [Abstract][Full Text] [Related]
14. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states. Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone and prolactin release in acromegalic patients following metergoline administration. Delitala G; Masala A; Alagna S; Devilla L; Lotti G J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821 [TBL] [Abstract][Full Text] [Related]
16. Age-related alteration of the hypothalamic-pituitary-gonadal axis in sexually impotent males. Benkert O; Witt W Acta Psychiatr Belg; 1980; 80(4):465-75. PubMed ID: 6792867 [TBL] [Abstract][Full Text] [Related]
17. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine. Krulich L; McCann SM; Mayfield MA Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261 [TBL] [Abstract][Full Text] [Related]
18. Effect of three serotonin antagonists on plasma prolactin response to suckling in puerperal women. Crosignani PG; Lombroso GC; Mattei A; Caccamo A; Trojsi L J Clin Endocrinol Metab; 1979 Feb; 48(2):335-7. PubMed ID: 429487 [TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia: a possible cause of sexual impotence in male patients undergoing chronic hemodialysis. Gura V; Weizman A; Maoz B; Zevin D; Ben-David M Nephron; 1980; 26(1):53-4. PubMed ID: 7393379 [TBL] [Abstract][Full Text] [Related]